Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (711-720 of 1,123) with videos related to

Pageof 113
Sort By:
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Cancer Research|May 31, 2002
2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitorsThomas Beckers, Thomas Reissmann, Mathias Schmidt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 31, 2009
Reasons for not seeking medical help for severe pelvic floor symptoms: a qualitative study in survivors of gynaecological cancerM H Hazewinkel, M A G Sprangers, E F Taminiau-Bloem, et al.
Antiviral Therapy|August 6, 2011
The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentrationWouter F W Bierman, Marit G A van Vonderen, Agnes I Veldkamp, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Adherence to HIV therapeutic drug monitoring guidelines in The NetherlandsMatthijs van Luin, Ferdinand W Wit, Colette Smit, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agentsRoger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom G Jacobs, Elin M Svensson, Victor Musiime, et al.
Pageof 113

Showing results (711-720 of 1,123) with videos related to

Sort By:
Pageof 113
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Cancer Research|May 31, 2002
2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitorsThomas Beckers, Thomas Reissmann, Mathias Schmidt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 31, 2009
Reasons for not seeking medical help for severe pelvic floor symptoms: a qualitative study in survivors of gynaecological cancerM H Hazewinkel, M A G Sprangers, E F Taminiau-Bloem, et al.
Antiviral Therapy|August 6, 2011
The lopinavir/ritonavir-associated rise in lipids is not related to lopinavir or ritonavir plasma concentrationWouter F W Bierman, Marit G A van Vonderen, Agnes I Veldkamp, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.
Therapeutic Drug Monitoring|December 31, 2010
Adherence to HIV therapeutic drug monitoring guidelines in The NetherlandsMatthijs van Luin, Ferdinand W Wit, Colette Smit, et al.
AIDS Research and Human Retroviruses|October 27, 2007
Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) StudyJose A Muñoz-Moreno, Carmina R Fumaz, Maria J Ferrer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2009
Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agentsRoger J M Brüggemann, Jan-Willem C Alffenaar, Nicole M A Blijlevens, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom G Jacobs, Elin M Svensson, Victor Musiime, et al.
Pageof 113